SUBSCRIBE
SUBSCRIBE
News   Business

Lonza Group Ltd. and Osiris Therapeutics, Inc. Enter Strategic Product Supply Agreement

July 2, 2008 | 
1 min read
Lonza (SWX: LONN), today announces a clinical and commercial manufacturing agreement with Osiris Therapeutics, Inc. (NASDAQ:OSIR) for the production of Prochymal®, their leading adult stem cell therapy
Alliances Europe
Lonza
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Schrödinger Downsizes by 7% in Savings Push
May 21, 2025
 · 
209 min read
 · 
BioSpace Editorial Staff
Podcast
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
May 21, 2025
 · 
2 min read
 · 
Heather McKenzie
Metal pipe with empty flange covering the end. A PVC pipe with metal joins and flanges with bolts.
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
May 21, 2025
 · 
5 min read
 · 
Michael N. Abrams
Handshake in retro collage style. Hands with halftone effect make a deal, a hand comes out of a laptop, online deals. Vector modern illustration.
Collaboration
CRISPR Expands Focus, Pays Up To $95M in Sirius’ siRNA Pact
May 20, 2025
 · 
2 min read
 · 
Tristan Manalac